Promoting Excellence : Treatment Protocol for Uremic Neuropathy in ESRD

Name:
Renal Palliative Care Initiative: Treatment Protocol for Uremic Neuropathy in ESRD

Description:
This treatment protocol was created to address and manage occurrence of uremic neuropathy in patients with end stage renal disease.

Category:
Clinical Care Tools - Symptom Management

Source:
Renal Palliative Care Initiative
Baystate Medical Center
759 Chestnut Street S2669
Springfield, MA 01199

Contact:
Michael Germain, M.D.
[email protected]

How the grantee used this instrument:
This protocol was made available at the clinics and renal unit nursing stations.

Keywords:
esrd, end stage renal disease, uremic neuropathy, dialysis, kidney disease, symptom assessment

To use this tool:
You may print and copy this tool for your own use from this site. Please credit source.

References:

  1. Callaghan, N. "Restless legs symdrome in uremic neuropathy." Neurology, 1966; 16: 359.
  2. Walker, S., Fine, A., & Kryger, M.H. "Sleep complaints are common in a dialysis unit." American Journal of Kidney Diseases, 1995; 26:751.
  3. Harris, DC, Chapman, JR, Stewart, KH, et al. "Low dose erythropoietin in maintenance hemodialysis: Improvement in quality of life and reduction in true cost of hemodialysis." Australian & New Zealand Journal of Medicine, 1991; 21:693.
  4. Roger, SD, Harris, DCH, & Stewart, JH. "Possible relation between restless legs and anaemia in renal dialysis patients." Lancet, 337: 1551.
  5. O'Keefe, St, Gavin, K, Lavan, JN. "Iron status and restless leg syndrome in the elderly." Age Ageing, 1994;23:200.
  6. Collado-Seidel, V, Kohnen, R, Samtleben, W, et al. "Clinical and biochemical findings in uremic patients with and without restless legs syndrome." American Journal of Kidney Diseases, 1998; 31:132.
  7. Winkelman, JW, Cherow, GM, & Lazarus, JM. "Restless legs syndrome in end-stage renal disease." American Journal of Kidney Diseases, 1996; 28: 372.
  8. Hening, WA. "Therapeutic approaches to restless legs syndrome and periodic limb movement disorder." Hospital Medicine, 1997; 33: 135.
  9. Schenck, CH, Mahowald, MW. "Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults." American Journal of Medicine,1996; 100:333
  10. Allen, RP, & Earley, CJ, "Augmentation of the restless lege syndrome with carbidopa/levodopa." Journal of Sleep Research, 1996; 19: 205.
  11. Von Scheele, C, Kempe, V. "Long-term effect of dopaminergic drugs in restless legs: A 2-year follow-up." Archives of Neurology, 1990; 47:1223.
  12. Silber, MH, Shepart, JW Jr, Wisbey, JA. "Pergolide in the management of restless legs syndrome: An extended study." Journal of Sleep Research, 1997; 20:878.
  13. Thorp, ML, Morris, CD, Bagby, SP. "A crossover study of gabapentim in treatment of restless legs syndrome among hemodialysis patients." American Journal of Kidney Diseases, 2001;38:104.
  14. Wagner, ML, Walters, AS, Coleman, et.al. "Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome." 1996; 19:52.
  15. Walters, AS, Wagner, ML, Hening, WA, et al. "Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo." Journal of Sleep Research, 1993; 16:327.

To view this tool:
Left click on the download link to view the PDF document in your Web browser. Right-click on the download link to save the document to your computer.
pdf PDF 65 KB / 1 page (Viewing PDF files requires downloading and installation of the free Adobe Acrobat Reader.)

Posted April 2004

Baystate Medical Center overview page


# BMC13, type:symptom_management


Promoting Excellence in End-of-Life Care was a national program of the Robert Wood Johnson Foundation dedicated to long-term changes in health care institutions to substantially improve care for dying people and their families. Visit PromotingExcellence.org for more resources.

Promoting Excellence logo and link to home page